| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.84M | 15.02M | 15.18M | 14.12M | 13.21M | 8.37M |
| Gross Profit | 8.25M | 10.42M | 10.43M | 9.38M | 8.56M | 5.06M |
| EBITDA | 4.43M | 4.17M | 3.82M | 3.46M | 2.65M | -539.00K |
| Net Income | 1.07M | 857.00K | 801.00K | 161.00K | 187.00K | -1.96M |
Balance Sheet | ||||||
| Total Assets | 33.73M | 34.01M | 34.95M | 32.78M | 33.33M | 33.75M |
| Cash, Cash Equivalents and Short-Term Investments | 2.57M | 2.78M | 1.82M | 69.00K | 1.58M | 1.89M |
| Total Debt | 3.15M | 3.32M | 3.62M | 3.63M | 4.61M | 4.61M |
| Total Liabilities | 6.87M | 6.87M | 7.75M | 6.81M | 7.59M | 7.95M |
| Stockholders Equity | 26.86M | 27.14M | 27.19M | 25.97M | 25.73M | 25.80M |
Cash Flow | ||||||
| Free Cash Flow | 3.44M | 2.33M | 2.01M | -317.00K | -55.00K | -1.56M |
| Operating Cash Flow | 4.13M | 4.61M | 4.32M | 2.04M | 2.40M | 1.05M |
| Investing Cash Flow | -2.42M | -2.29M | -2.31M | -2.35M | -2.43M | -2.62M |
| Financing Cash Flow | -1.39M | -1.37M | 914.00K | -1.05M | -1.59M | 3.08M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £47.86M | 6.47 | 6.92% | ― | 7.16% | -11.00% | |
76 Outperform | £2.14B | 13.52 | 20.62% | 2.58% | 11.42% | -17.18% | |
66 Neutral | £17.34M | 22.01 | 3.96% | 2.14% | -5.27% | 8.93% | |
65 Neutral | £5.59B | 21.21 | 31.07% | 3.44% | 1.14% | 17.74% | |
65 Neutral | £11.61B | 31.67 | 5.93% | 1.68% | -1.58% | -34.64% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
41 Neutral | £284.37M | -2.81 | -142.88% | ― | -4.87% | ― |